FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for ...
New postmarketing reports link Adzynma to neutralizing antibodies and a fatality, leading the FDA to evaluate the need for updated labeling.
MedPage Today on MSN
FDA Probes Child Death Linked to Drug for Blood Clotting Disorder
The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients ...
FDA investigates Takeda's blood disorder drug after pediatric death; Australia blocks a $435 million buyout offer for Mayne Pharma from Cosette Pharmaceuticals; Eli Lilly becomes first $1 trillion ...
The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the ...
The U.S. Food and Drug Administration said on Friday it is investigating the death of a child who developed harmful ...
Takeda Pharmaceuticals' drug Adzynma is being investigated by the U.S. Food and Drug Administration due to a death following treatment. The FDA said Friday it has received reports of neutralizing ...
When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...
This is very exciting! The good activity and highly conserved epitope of this antibody suggested its potential for clinical translation". Dr. Hang Su, Shenzhen University The team found the mAb-39 ...
An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback